So, UiPath Inc. (PATH) had a bit of a confusing day. The company reported quarterly numbers that were, by all accounts, pretty good. They beat expectations. And yet, the stock traded lower. It's one of those classic market moments where what you did yesterday matters less than what you promise for tomorrow.
The software automation company posted fourth-quarter revenue of $481.11 million, comfortably above the $464.49 million analysts were looking for. Adjusted earnings came in at 30 cents a share, topping estimates of 26 cents. By the standard report card, that's an A. But the market is a forward-looking grader, and UiPath's outlook for fiscal 2027—yes, the year that starts in 2026—seemed to give investors pause. The company expects first-quarter revenue between $395 million and $400 million and sees full fiscal 2027 revenue ranging from $1.754 billion to $1.759 billion. It was that longer-term guide, perceived as measured or cautious, that kept pressure on the shares even after a strong beat.
The CEO's Big Bet on AI and Automation
Founder and CEO Daniel Dines had a clear message for investors: the future is "agentic automation." He argued that as software becomes cheaper and easier to create, the real value shifts to orchestration, governance, and execution. In other words, it's not just about having smart tools; it's about having a reliable, compliant system to manage them all, especially as AI adoption grows in enterprises.
The numbers back up his focus. Dines said UiPath's AI product annual recurring revenue (ARR) reached nearly $200 million in the quarter. Perhaps more tellingly, 16 of the company's 20 largest deals included AI products. Management emphasized that customers are integrating AI into their existing workflows rather than using it to replace core automation processes. It's an expansion story, not a replacement one.
On the financial side, Chief Operating and Financial Officer Ashim Gupta pointed to improved coordination across sales, product, and customer success teams. He also set an expectation for "meaningful GAAP profitability" in fiscal 2027 and noted that current foreign exchange trends should have an immaterial impact for the full year.
Wall Street's Mixed Report Card
Analysts, like the market, couldn't quite agree on what to make of it all.
On the bullish side, Needham analyst Scott Berg upgraded the stock from Hold to Buy and set a price target of $15. His thesis is straightforward: the valuation looks compelling. Berg believes UiPath could trade closer to 15 times its trailing-12-month free cash flow, even in today's challenging macroeconomic environment. He sees potential for improving sales trends to drive free cash flow growth that outpaces his current, conservative assumptions.
Other analysts were more measured. D.A. Davidson's Lucky Schreiner maintained a Neutral rating with a $13 price target. He noted that factors like the impact of the WorkFusion acquisition, foreign exchange tailwinds, and limited margin expansion likely pressured the stock after hours. While he acknowledged UiPath's business appears more stable and its guidance points to continued acceleration in net new ARR, he argued the stock's current price already reflects that growth outlook, limiting near-term upside.
Wells Fargo analyst Michael Turrin also maintained an Equal-Weight rating, though he lowered his price target from $14 to $13.
In the end, the narrative that won the day was one of caution over celebration. Strong quarterly execution was overshadowed by a long-term guide that didn't dazzle. UiPath shares finished the day down 6.38% at $11.59. It's a reminder that in the stock market, an A on the last test isn't always enough if the class syllabus for the next few years looks a bit less exciting.
